Estimating the respiratory syncytial virus-associated hospitalisation burden in older adults in European countries: a systematic analysis
With respiratory syncytial virus vaccines recently approved for use among older adults, country‑level respiratory syncytial virus (RSV) disease burden estimates are needed to inform local RSV immunisation strategy. We aimed to estimate country‑level RSV hospitalisation burden in older adults in Euro...
| Autores: | , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Universidad Católica de Valencia San Vicente Mártir |
| Repositorio: | RIUCV. Repositorio de la Universidad Católica de Valencia San Vicente Mártir |
| Idioma: | inglés |
| OAI Identifier: | oai:riucv.ucv.es:20.500.12466/6753 |
| Acceso en línea: | https://hdl.handle.net/20.500.12466/6753 |
| Access Level: | acceso abierto |
| Palabra clave: | Respiratory syncytial virus Hospitalisation Burden of disease Older adults 32 Ciencias Médicas |
| Sumario: | With respiratory syncytial virus vaccines recently approved for use among older adults, country‑level respiratory syncytial virus (RSV) disease burden estimates are needed to inform local RSV immunisation strategy. We aimed to estimate country‑level RSV hospitalisation burden in older adults in Europe. |
|---|